Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tackles HIV drug resistance in patients with persistent high viral loads

NCT ID NCT01976715

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times

Summary

This study aims to understand why some people with HIV still have high virus levels despite taking combination antiretroviral therapy (ART). Researchers will monitor 26 participants during hospital stays and follow-ups to see if directly observed medication and tailored support can help control the virus. The goal is to improve treatment strategies for those who experience virologic failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.